Rapid Micro Biosystems (NASDAQ:RPID) Raised to “Hold” at Wall Street Zen

Rapid Micro Biosystems (NASDAQ:RPID) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday.

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research note on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $8.00.

Rapid Micro Biosystems Stock Performance

NASDAQ:RPID opened at $3.91 on Friday. Rapid Micro Biosystems has a fifty-two week low of $1.86 and a fifty-two week high of $4.94. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.95 and a current ratio of 4.23. The company has a 50 day moving average price of $3.66 and a 200 day moving average price of $3.39. The stock has a market capitalization of $173.29 million, a P/E ratio of -3.87 and a beta of 1.38.

Insider Buying and Selling at Rapid Micro Biosystems

In other news, CEO Robert G. Jr. Spignesi sold 12,840 shares of the business’s stock in a transaction dated Monday, February 9th. The stock was sold at an average price of $3.78, for a total transaction of $48,535.20. Following the completion of the transaction, the chief executive officer directly owned 962,097 shares of the company’s stock, valued at approximately $3,636,726.66. The trade was a 1.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Longitude Capital Partners Ii, sold 49,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $3.88, for a total transaction of $190,120.00. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 153,716 shares of company stock valued at $635,998 over the last three months. 29.96% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in RPID. Marshall Wace LLP acquired a new stake in shares of Rapid Micro Biosystems in the 4th quarter valued at $182,000. Jane Street Group LLC raised its stake in Rapid Micro Biosystems by 176.1% in the fourth quarter. Jane Street Group LLC now owns 105,301 shares of the company’s stock valued at $305,000 after buying an additional 67,161 shares in the last quarter. Renaissance Technologies LLC raised its stake in Rapid Micro Biosystems by 4.9% in the fourth quarter. Renaissance Technologies LLC now owns 115,627 shares of the company’s stock valued at $335,000 after buying an additional 5,440 shares in the last quarter. Informed Momentum Co LLC purchased a new stake in Rapid Micro Biosystems during the 4th quarter worth about $224,000. Finally, Goldman Sachs Group Inc. acquired a new position in shares of Rapid Micro Biosystems during the 4th quarter worth about $160,000. Institutional investors and hedge funds own 52.60% of the company’s stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.